Safety and Tolerability of the Ophthalmic Gel PRO-167 Versus Corneregel® on Healthy Subjects.
Status:
Completed
Trial end date:
2018-07-16
Target enrollment:
Participant gender:
Summary
Title of the study:
Phase I clinical trial, to evaluate the safety and tolerability of the ophthalmic gel PRO-167
versus Corneregel®, on the ocular surface of ophthalmological and clinically healthy
subjects.
Methodology:
Phase I clinical trial, controlled, of parallel groups, double blind, randomized,
exploratory.
Goals:
To evaluate the safety and tolerability of the ophthalmic gel PRO-167 manufactured by
Laboratorios Sophia S.A. of C.V. on the ocular surface of clinically healthy subjects.
Hypothesis:
Ophthalmic gel PRO-167 has a safety and tolerability profile similar to that of its
comparator in healthy subjects.